Toshihiko Yamaka
Overview
Explore the profile of Toshihiko Yamaka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abe T, Matsuo H, Abe R, Abe S, Asada H, Ashida A, et al.
Ther Apher Dial
. 2021 Dec;
25(6):728-876.
PMID: 34877777
Most of the diseases for which apheresis therapy is indicated are intractable and rare, and each patient has a different background and treatment course prior to apheresis therapy initiation. Therefore,...
2.
Komatsuzaki Y, Ikeda M, Shimizu A, Matsuo N, Maruyama Y, Yokoo T, et al.
Sci Rep
. 2021 Feb;
11(1):4600.
PMID: 33633262
The traditional anion gap (AG) equation is widely used, but its misdiagnosis in end-stage kidney disease (ESKD) patients has not been investigated fully. Diagnostic accuracy to detect high AG was...
3.
Hayashi T, Tanaka Y, Iwasaki M, Hase H, Yamamoto H, Komatsu Y, et al.
J Ren Nutr
. 2018 Aug;
29(1):39-47.
PMID: 30097326
Objectives: High prevalence of iron deficiency (ID) and cardiomyopathy have been observed in patients with end-stage kidney disease (ESKD). Our objective was to clarify associations between ID and cardiac remodeling...
4.
Hanafusa N, Isoai A, Ishihara T, Inoue T, Ishitani K, Utsugisawa T, et al.
PLoS One
. 2017 May;
12(5):e0177303.
PMID: 28510606
We performed post-marketing surveillance to evaluate the safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART). In total, 356 CART sessions in 147 patients at 22 centers were...
5.
Ikeda M, Ueda Y, Maruyama Y, Yokoyama K, Yokoo T, Joki N, et al.
Clin Exp Nephrol
. 2016 Nov;
21(5):825-834.
PMID: 27844184
Background: Nausea is a major uremic symptom and a frequent indication for starting dialysis. However, preventive medication for uremic nausea has not yet been identified. Vitamin D receptor activators (VDRAs)...
6.
Ikeda M, Nakao M, Hirano K, Yokoyama K, Yokoo T, Joki N, et al.
J Renin Angiotensin Aldosterone Syst
. 2015 Jul;
16(4):1175-84.
PMID: 26195266
Background: Preventive medications for dialysis-requiring congestive heart failure (CHF) in non-dialysis Japanese patients with Stage 5 chronic kidney disease (CKD) are unknown. Our aim was to explore which CKD medication...
7.
Asakawa T, Joki N, Tanaka Y, Hayashi T, Hase H, Komatsu Y, et al.
Cardiorenal Med
. 2015 Mar;
4(3-4):189-200.
PMID: 25737683
Background/aim: The present study explores associations between hemoglobin (Hb) levels and patients with cardiac enlargement in end-stage kidney disease (ESKD) to help prevent cardiac remodeling during the predialysis phase of...
8.
Ohya M, Negi S, Sakaguchi T, Koiwa F, Ando R, Komatsu Y, et al.
J Clin Endocrinol Metab
. 2014 Jun;
99(10):3873-8.
PMID: 24937533
Context: PTH is a critical factor in mineral homeostasis, and chronic kidney disease mineral and bone metabolism disorder is a very important problem in patients with renal failure. Abnormal levels...
9.
Tanaka Y, Joki N, Hase H, Iwasaki M, Ikeda M, Ando R, et al.
J Inflamm (Lond)
. 2012 May;
9(1):17.
PMID: 22583484
Background: The goal of the present study was to explore the effect of medications that are commonly prescribed for CKD patients on uremic state. Methods: This was a cross-sectional study....
10.
Yoshimura N, Tadami T, Kawaguchi T, Sako M, Yoshimoto H, Yamaka T, et al.
J Gastroenterol
. 2011 Sep;
47(1):49-55.
PMID: 21915624
Background: Hitherto, therapeutic depletion of granulocytes and monocytes by adsorption (GMA) has been associated with significant and insignificant efficacy in patients with ulcerative colitis (UC). Further, the processed blood volume...